Literature DB >> 11356036

Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan.

B Tyrberg1, A Andersson, L A Borg.   

Abstract

The beta-cell toxin alloxan, which produces oxygen radicals, is a model substance in studies of type 1 diabetes. Recently, human beta-cells have been found to be relatively resistant to this toxin. To clarify species differences in alloxan diabetogenicity, and oxygen radical toxicity, mouse, rat, rabbit, dog, pig, human and guinea pig islets have been studied after alloxan exposure. Using a standardized in vivo model, where islets were transplanted to nude mice, the different islets were compared. The results demonstrated that mouse and rat islet grafts were morphologically disturbed by alloxan and ROS. Rabbit and dog islet graft morphology was reasonably intact; and human, porcine, and guinea pig islet grafts were all well preserved. Furthermore, ultrastructural signs of apoptosis and necrosis, disturbances in the insulin secretory pattern during and after an alloxan perifusion, and islet lysosomal enzyme activities were studied in vitro in islets from some species. Guinea pig beta-cells were affected by alloxan, but a regeneration process compensated for the observed apoptotic and necrotic cell death. Human islets did not show any signs of alloxan-induced damage in the different models studied. Finally, no correlation between high alloxan sensitivity and high lysosomal enzyme activity was found. Thus, the beta-cell lysosomes are hardly specific targets for alloxan. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356036     DOI: 10.1006/gcen.2001.7638

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  19 in total

1.  Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan.

Authors:  M Elsner; M Tiedge; S Lenzen
Journal:  Diabetologia       Date:  2003-11-12       Impact factor: 10.122

Review 2.  beta-cell Regeneration: neogenesis, replication or both?

Authors:  Fred Levine; Pamela Itkin-Ansari
Journal:  J Mol Med (Berl)       Date:  2007-10-06       Impact factor: 4.599

Review 3.  Effects of exercise on brain functions in diabetic animal models.

Authors:  Sun Shin Yi
Journal:  World J Diabetes       Date:  2015-05-15

4.  The use of animal models in diabetes research.

Authors:  Aileen J F King
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

5.  Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies.

Authors:  Seung-Hee Lee; Ergeng Hao; Alexei Y Savinov; Ifat Geron; Alex Y Strongin; Pamela Itkin-Ansari
Journal:  Transplantation       Date:  2009-04-15       Impact factor: 4.939

6.  Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets.

Authors:  J Olerud; N Kanaykina; S Vasylovska; S Vasilovska; D King; M Sandberg; L Jansson; E N Kozlova
Journal:  Diabetologia       Date:  2009-10-13       Impact factor: 10.122

7.  Direct continuities between cisternae at different levels of the Golgi complex in glucose-stimulated mouse islet beta cells.

Authors:  Brad J Marsh; Niels Volkmann; J Richard McIntosh; Kathryn E Howell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

8.  Strychnos nux-vomica seeds: Pharmacognostical standardization, extraction, and antidiabetic activity.

Authors:  Rajesh Bhati; Anupama Singh; Vikas Anand Saharan; Veerma Ram; Anil Bhandari
Journal:  J Ayurveda Integr Med       Date:  2012-04

9.  Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets.

Authors:  C Dai; M Brissova; Y Hang; C Thompson; G Poffenberger; A Shostak; Z Chen; R Stein; A C Powers
Journal:  Diabetologia       Date:  2011-12-14       Impact factor: 10.122

10.  Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression.

Authors:  Dalit Tchorsh-Yutsis; Gil Hecht; Anna Aronovich; Elias Shezen; Yael Klionsky; Chava Rosen; Rivka Bitcover; Smadar Eventov-Friedman; Helena Katchman; Sivan Cohen; Orna Tal; Oren Milstein; Hideo Yagita; Bruce R Blazar; Yair Reisner
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.